Medexus Pharmaceuticals Inc. (MDP.TO) TSX

Currency In CAD

AD

Valuation

Market Cap100.83M
Enterprise Value116.57M
P/E Ratio-47.53
PEG Ratio-0.59
Price/Sales Ratio1.12
Price/Book Ratio2.42
Enterprise/Revenue1.32
Enterprise/EBITDA10.74

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.02
Operating Margin0.07
AD

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.05

Income Statement

Revenue99.33M
Revenue/Share3.25
Gross Profit54.41M
EBITDA12.66M
Net Income-2.39M
Diluted EPS-0.07

Balance Sheet

Total Cash5.34M
Total Cash/Share0.17
Total Debt26.21M
Total Debt/Equity0.55
Current Ratio1.3
Book Value Per Share1.51

Price History

52-Week Change63.23
52-Week High5.5
52-Week Low2.51
Moving Average 50 Days5.1
Moving Average 200 Days3.77

Statistics

Average Volume48,498
Shares Outstanding31.66M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:15
Last Split DateDecember 19, 2018
AD